INNV
InnovAge Holding Corp.NASDAQHealthcare$7.61-5.11%ClosedMarket Cap: $1.03B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.02
P/S
1.13
EV/EBITDA
40.70
DCF Value
$-6.07
FCF Yield
4.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
19.8%
Operating Margin
0.4%
Net Margin
-0.5%
ROE
-1.7%
ROA
-1.1%
ROIC
1.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $239.7M | 20.0% | $16.1M | $10.6M | $0.08 | — |
| Q1 2026 | $236.1M | 21.8% | $8.3M | $8.0M | $-0.08 | — |
| Q4 2025 | $218.1M | 18.7% | $-10.2M | $-11.4M | $-0.08 | — |
| FY 2025 | $853.7M | 68.5% | $-29.8M | $-30.3M | $-0.22 | — |
| Q3 2025 | $218.1M | 18.7% | $-10.2M | $-11.4M | $-0.08 | — |
| Q2 2025 | $209.0M | 17.7% | $-12.6M | $-13.2M | $-0.10 | — |
| Q1 2025 | $205.1M | 16.8% | $-4.9M | $-4.9M | $-0.04 | — |
| Q4 2024 | $199.4M | 18.3% | $-4.9M | $-1.7M | $-0.01 | — |
| FY 2024 | $763.9M | 17.3% | $-23.2M | $-21.3M | $-0.16 | — |
| Q3 2024 | $193.1M | 17.6% | $-5.8M | $-5.9M | $-0.04 | — |
| Q2 2024 | $188.9M | 17.8% | $-1.8M | $-3.4M | $-0.03 | — |
| Q1 2024 | $182.5M | 15.3% | $-10.7M | $-10.3M | $-0.08 | — |